Trisubstituted 1,2,4-triazoles for modulating the alpha7 nicotinic receptor

Disclosed is a compound of formula (I), or an N-oxide, pharmaceutically acceptable addition salt, solvate, quaternary amine or stereoisomer thereof, wherein the substituents are as described in the specification. Also disclosed is the use of the compound for treating diseases or conditions which ben...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	THURING, JOHANNES WILHELMUS JOHN F, DE BRUYN, MARCEL FRANS LEOPOLD, VAN ROOSBROECK, YVES EMIEL MARIA, LESAGE, ANNE SIMONE JOSEPHINE, VAN DEN KEYBUS, FRANS ALFONS MARIA, ZHUANG, WEI, DUFFY, JAMES EDWARD STEWART, MACDONALD, GREGOR, JAMES, DINKLO, THEODORUS
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed is a compound of formula (I), or an N-oxide, pharmaceutically acceptable addition salt, solvate, quaternary amine or stereoisomer thereof, wherein the substituents are as described in the specification. Also disclosed is the use of the compound for treating diseases or conditions which benefit from the modulation of the alpha7 nicotinic receptor.